Comment from Consumer Healthcare Products Association (CHPA)

Summary: The Consumer Healthcare Products Association (CHPA), a trade association representing manufacturers of over-the-counter medicines, opposes the proposed label change for acetaminophen. They argue that there is no established causal link between prenatal acetaminophen use and neurodevelopmental disorders, and that current labeling already provides sufficient guidance for pregnant women.